| Health Care Equipment & Supplies Industry | Healthcare Sector | Kevin S. Wilson CEO | NASDAQ (CM) Exchange | 42805E306 CUSIP |
| US Country | 808 Employees | 26 Sep 2012 Last Dividend | 30 Dec 2010 Last Split | - IPO Date |
Heska Corporation is a dedicated provider of specialized diagnostic and animal health products primarily targeting the canine and feline veterinary care markets. The company operates across several countries, including the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Founded in 1988 as Paravax, Inc. and rebranded in 1995, Heska has established itself as a leader in veterinary diagnostics and treatment solutions. The headquarters of Heska Corporation is located in Loveland, Colorado, where it develops and distributes a diverse range of innovative products for veterinarians and animal health professionals.
Heska offers a variety of advanced veterinary chemistry analyzers including Element DC, DCX, and DC5x series. These systems are specifically designed for blood chemistry and electrolyte analysis, helping veterinarians to obtain vital health information of their canine and feline patients.
The Element HT5 and scil Vet abc Plus analyzers cater to hematological assessments, measuring essential parameters such as blood cell and platelet counts, as well as hemoglobin levels, thus assisting in comprehensive health evaluations.
Heska provides Element POC analyzers, which facilitate rapid blood gas and electrolyte testing needed for prompt diagnosis and treatment, as well as Element i immunodiagnostic analyzers for detecting various conditions.
The Element COAG and Element AIM veterinary analyzers are engineered for coagulation studies, offering veterinarians precise insights into their patients' blood clotting abilities.
Heska’s imaging solutions include HeskaView Telecytology, which automates microscopic slide scanning for clinical use, along with advanced IV infusion pumps, ensuring efficient treatment delivery. Additionally, digital radiography hardware, mobile units, sophisticated ultrasound systems, and Cloudbank for web-based image storage are part of their offerings.
The company produces rapid in-clinic products designed for the detection of antigens and antibodies related to infectious and parasitic diseases, offering veterinarians timely results to enhance patient care.
Heska specializes in therapeutic products such as Tri-Heart Plus chewable tablets for the effective treatment of canine heartworm as well as other parasitic infections, ensuring the health and well-being of pets.
With a focus on allergy management, Heska provides ALLERCEPT definitive allergen panels that assist in the diagnosis of allergies, alongside personalized therapy shots or drops tailored to each animal’s needs.
The company develops a comprehensive range of vaccines aimed at improving bovine health, reflecting its commitment to the broader spectrum of animal health.
Heska supplies an array of biological and pharmaceutical products to various animal health companies while also providing turnkey services that include research, licensing, production, labeling, packaging, validation support, and distribution.
These products are effectively distributed to veterinarians through a combination of direct telephone sales, third-party distributors, trade shows, print advertisements, and strategic partnerships, ensuring accessibility to cutting-edge veterinary care solutions.